Perioperative circulating tumor DNA as a potential prognostic marker for operable stage I to IIIA non–small cell lung cancer - Li, Ning; Wang, Bao‐Xiao; Li, Jian; Shao, Yang; Li, Ming‐Tian; Li, Jian‐Jun; Kuang, Peng‐Peng; Liu, Zui; Sun, Tian‐Yu; Wu, Hui‐Qi; Ou, Wei; Wang, Si‐Yu (Cancer, 2022)
Keywords: Biomarkers; Biomarkers, Tumor - blood; Carcinoma, Non-Small-Cell Lung - blood; Carcinoma, Non-Small-Cell Lung - surgery; circulating tumor DNA (ctDNA); Circulating Tumor DNA - blood; Deoxyribonucleic acid; DNA; Health risks; Humans; Lead time; Lung cancer; Lung Neoplasms - blood; Lung Neoplasms - surgery; Medical imaging; Medical prognosis; Metastases; Minimal residual disease; Monitoring; Neoplasm Recurrence, Local - blood; Neoplasm Recurrence, Local - pathology; Non-small cell lung carcinoma; non–small cell lung cancer (NSCLC); Oncology; Patients; Peripheral blood; Prognosis; Prospective Studies; recurrence; Risk assessment; Small cell lung carcinoma; Surgery; Survival; Telemedicine; Tumors; recurrence; circulating tumor DNA (ctDNA); prognosis; non-small cell lung cancer (NSCLC); surgery